Literature DB >> 4373570

On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock.

M L Errington, M Rocha e Silva.   

Abstract

1. Long-lasting haemorrhagic hypotension (4.5 hr at 35 mmHg) leading to irreversible haemorrhagic shock, has been studied in normal dogs, in dogs treated with a bradykinin potentiating nonapeptide (BPP(9a)), which blocks the conversion of angiotensin I to angiotensin II, and in dogs with experimental chronic diabetes insipidus (DI dogs). BPP(9a) was given by I.V. injection before the start of bleeding (BPP pre-treated group), 45 min after blood pressure had reached 35 mmHg (BPP early treated group) or 2 hr after blood pressure had reached 35 mmHg (BPP late-treated group). After retransfusion of blood all dogs were allowed to recover and observed for a further period of 3 days.2. Untreated control dogs developed haemorrhagic shock with tachycardia, low cardiac output, low total peripheral conductance and low stroke volume. All died within 24 hr of retransfusion, with pathological lesions typical of irreversible haemorrhagic shock.3. BPP pre-treated dogs developed haemorrhagic shock with bradycardia (during early shock), high cardiac output, high peripheral vascular conductance and high stroke volume when compared with the untreated controls. All pre-treated animals survived the 3 day observation period. They were then killed and on post-mortem showed no signs of irreversible haemorrhagic shock.4. BPP early-treated animals behaved like controls before BPP, but like pre-treated animals after the drug. Only one out of eight died within the 3 day observation period.5. BPP late-treated dogs behaved like controls before BPP. They responded to the drug with a rise in cardiac output, peripheral vascular conductance and stroke volume, and with a fall in heart rate. These responses were, however, short-lived. Four out of these eight animals died within the 3 day observation period, with lesions of irreversible haemorrhagic shock.6. DI dogs developed haemorrhagic shock with tachycardia (like controls), but with high cardiac output and peripheral vascular conductance (like BPP pre-treated dogs). The stroke volume of DI dogs was intermediate between those of controls and pre-treated groups. All six dogs survived the 3 day observation period.7. BPP(9a) had no measurable effect on the course of endotoxic shock.8. It is suggested that the normally severe vasoconstriction of the mesenteric vascular bed, which is thought to be responsible for irreversible haemorrhagic shock, is absent or attenuated in the absence of vasopressin or angiotensin. The consequences of this on the development of irreversibility are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373570      PMCID: PMC1330603          DOI: 10.1113/jphysiol.1974.sp010697

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  VASOPRESSIN POTENTIATION OF CATECHOLAMINE ACTIONS IN DOG, RAT, CAT, AND RAT AORTIC STRIP.

Authors:  H J BARTELSTONE; P A NASMYTH
Journal:  Am J Physiol       Date:  1965-04

2.  The intestinal factor in irreversible hemorrhagic shock.

Authors:  R C LILLEHEI
Journal:  Surgery       Date:  1957-12       Impact factor: 3.982

3.  Arterial blood epinephrine levels during hemorrhagic hypotension in dogs.

Authors:  D T WATTS
Journal:  Am J Physiol       Date:  1956-02

4.  A method for the assay of very small amounts of antidiuretic activity with a note on the antidiuretic titre of rat's blood.

Authors:  S E DICKER
Journal:  J Physiol       Date:  1953-10       Impact factor: 5.182

5.  Capacity of the neurohypophysis to release vasopressin.

Authors:  H Sachs; L Share; J Osinchak; A Carpi
Journal:  Endocrinology       Date:  1967-10       Impact factor: 4.736

6.  Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin.

Authors:  J R McNeill; R D Stark; C V Greenway
Journal:  Am J Physiol       Date:  1970-11

7.  Measurement of cardiac output by thermal dilution in man.

Authors:  M A Branthwaite; R D Bradley
Journal:  J Appl Physiol       Date:  1968-03       Impact factor: 3.531

8.  The continuous estimation of angiotensin formed in the circulation of the dog.

Authors:  D Regoli; J R Vane
Journal:  J Physiol       Date:  1966-04       Impact factor: 5.182

9.  Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation.

Authors:  J Hughes; R H Roth
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

10.  Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus.

Authors:  M L Errington; M Rocha e Silva
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

View more
  6 in total

1.  Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock.

Authors:  M Yamashita; T Oyama; T Kudo
Journal:  Can Anaesth Soc J       Date:  1977-11

2.  Hypometabolism and hypothermia in the rat model of endotoxic shock: independence of circulatory hypoxia.

Authors:  Joshua J Corrigan; Monique T Fonseca; Elizabeth A Flatow; Kevin Lewis; Alexandre A Steiner
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

3.  Effects of vasopressin on smooth muscle cells of guinea-pig mesenteric vessels.

Authors:  T Karashima
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

Review 4.  Heart failure in experimental refractory shock.

Authors:  I M Ledingham
Journal:  Eur J Intensive Care Med       Date:  1976-11

5.  Histochemical and ultrastructural study of renal cortical necrosis in rats treated with oestrone + vasopressin, and its prevention with a vasopressin antagonist.

Authors:  J Kocsis; G Karácsony; S Karcsú; F A László
Journal:  Br J Exp Pathol       Date:  1987-02

6.  The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit.

Authors:  T Bennett; P H Fentem; D R Tomlinson; D Yates
Journal:  Pflugers Arch       Date:  1976-09-03       Impact factor: 3.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.